SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-247479
Filing Date
2007-11-14
Accepted
2007-11-14 16:48:50
Documents
11
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 290480
2 LOAN AND SECURITY AGREEMENT dex1040.htm EX-10.40 106341
3 SECURED PROMISSORY NOTE dex1041.htm EX-10.41 11958
4 FORM OF WARRANT ISSUED TO LIFE SCIENCES CAPITAL LLC dex1042.htm EX-10.42 34320
5 OFFICE LEASE dex1043.htm EX-10.43 302383
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5349
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5329
8 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 4771
9 GRAPHIC g12526img_001.jpg GRAPHIC 125497
10 GRAPHIC g12526img_002.jpg GRAPHIC 118437
11 GRAPHIC g12526img_003.jpg GRAPHIC 117040
  Complete submission text file 0001193125-07-247479.txt   1260434
Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 071245805
SIC: 2836 Biological Products, (No Diagnostic Substances)